ASCO22: breast cancer patients over 55 years old may not need radiation therapy

A single-arm prospective Phase III trial, LUMINA, has suggested that patients who are 55 years of age and older with low-grade luminal A-type breast cancer may only need endocrine therapy following breast-conserving surgery and could avoid radiation therapy entirely. The study was recently presented at the 2022 American Society of Clinical Oncology (ASCO) Annual Meeting (3–6 June; Chicago, IL, USA) and could impact many patients who have very low chances of their breast cancer returning without radiation therapy. You may also be interested in: ASCO22: sacituzumab govitecan yields promising results for HR+/HER2- metastatic breast cancer ASCO22: practice-changing results for high-dose...